COVID-19, SARS and MERS: A neurological perspective

WHO. Coronavirus disease (COVID-19) Pandemic; 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed on: 28 April 2020].

WHO. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS); 2020. Available from: https://apps.who.int/iris/handle/10665/70863 [Accessed on: 28 April 2020].

WHO. Middle East respiratory syndrome coronavirus (MERS-CoV); 2020. Available from: https://www.who.int/emergencies/mers-cov/en/ [Accessed on: 28 April 2020].

Cui, 2019, Origin and evolution of pathogenic coronaviruses, Nat Rev Microbiol, 17, 181, 10.1038/s41579-018-0118-9

van Doremalen, 2020, Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med, 382, 1564, 10.1056/NEJMc2004973

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Lauer, 2020, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, 172, 577, 10.7326/M20-0504

Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 17, 259, 10.1038/s41569-020-0360-5

Mao, 2020, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China, Jama Neurol., 10.1001/jamaneurol.2020.1127

Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. SSRN 2020; Available at SSRN: https://ssrn.com/abstract=3550025.

Helms, 2020, Neurologic features in severe SARS-CoV-2 infection, N Engl J Med, 10.1056/NEJMc2008597

Karimi, 2020, Frequent convulsive seizures in an adult patient with COVID-19: a case report, Iran Red Crescent Med J, 22, 10.5812/ircmj.102828

Zhao, 2020, Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?, Lancet Neurol, 10.1016/S1474-4422(20)30109-5

Poyiadji, 2020, COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features, Radiology, 10.1148/radiol.2020201187

Moriguchi, 2020, A first case of meningitis/encephalitis associated with SARS-Coronavirus-2, Int J Infect Dis, 10.1016/j.ijid.2020.03.062

Zhao, 2020, Acute myelitis after SARS-CoV-2 infection: a case report, medRxiv, 2020

Sedaghat, 2020, Guillain Barre syndrome associated with COVID-19 infection: a case report, J. Clin. Neurosci., 10.1016/j.jocn.2020.04.062

Toscano, 2020, Guillain-Barré syndrome associated with SARS-CoV-2, N Engl J Med, 10.1056/NEJMc2009191

Lau, 2004, Possible central nervous system infection by SARS coronavirus, Emerg Infect Dis, 10, 342, 10.3201/eid1002.030638

Tsai, 2005, Neurological manifestations in severe acute respiratory syndrome, Acta Neurol Taiwan, 14, 113

Hung, 2003, Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome, Clin Chem, 49, 2108, 10.1373/clinchem.2003.025437

Chao, 2003, Peripheral nerve disease in SARS: report of a case, Neurology, 61, 1820, 10.1212/01.WNL.0000099171.26943.D0

Xu, 2005, Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis, Clin Infect Dis, 41, 1089, 10.1086/444461

Umapathi, 2004, Large artery ischaemic stroke in severe acute respiratory syndrome (SARS), J Neurol, 251, 1227, 10.1007/s00415-004-0519-8

Kim, 2017, Neurological complications during treatment of Middle East respiratory syndrome, J Clin Neurol, 13, 227, 10.3988/jcn.2017.13.3.227

Algahtani, 2016, Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature, Case Rep Neurol Med

Arabi, 2015, Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV), Infection, 43, 495, 10.1007/s15010-015-0720-y

Saad, 2014, Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia, Int J Infect Dis, 29, 301, 10.1016/j.ijid.2014.09.003

Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570

Chen, 2020, The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain, bioRxiv, 2020, 07.030650

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7

Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507

Netland, 2008, Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2, J Virol, 82, 7264, 10.1128/JVI.00737-08

Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 10.1016/S2213-2600(20)30116-8

Desforges, 2019, Coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?, Viruses, 12, 10.3390/v12010014

Fodoulian, 2020, SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium, bioRxiv, 2020, 31.013268

Brann, 2020, Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia, bioRxiv, 2020, 25.009084

Hwang, 2006, Olfactory neuropathy in severe acute respiratory syndrome: report of A case, Acta Neurol Taiwan, 15, 26

Lechien, 2020, Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study, Eur Arch Otorhinolaryngol, 10.1007/s00405-020-05965-1

Menni, 2020, Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection, medRxiv, 2020

Wölfel, 2020, Virological assessment of hospitalized patients with COVID-2019, Nature, 10.1038/s41586-020-2196-x

Giacomelli, 2020, Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: a cross-sectional study, Clin Infect Dis, 10.1093/cid/ciaa330

Bagheri, 2020, Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak, medRxiv, 2020

Wang, 2020, Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China, Int J Infect Dis

Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, 10.1172/JCI137244

Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0

Jin, 2020, Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists, Stroke Vasc Neurol, 10.1136/svn-2020-000382

Khosravani, 2020, Protected code stroke, Stroke, 10.1161/STROKEAHA.120.029838

Waldman, 2020, Preparing a neurology department for SARS-CoV-2 (COVID-19): early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City, Neurology, 10.1212/WNL.0000000000009519

Majersik, 2020, Acute neurology during the COVID-19 pandemic, Neurology, 10.1212/WNL.0000000000009564

Novi, 2020, COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?, Multiple Sclerosis Related Disorders, 42, 10.1016/j.msard.2020.102120